Lidocaine Hci Injection, Solution
Product Images NDC 51662-1416

13 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Lidocaine Hci (NDC 51662-1416). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

Description (Description)
A table presenting concentrations of lidocaine HCl (anhydrous) and sodium chloride in mg/mL across four solution strengths: 0.50%, 1%, 1.50%, and 2%. The lidocaine HCl concentration increases from 5 to 20 mg/mL, while sodium chloride concentration decreases from 8 to 6 mg/mL.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of lidocaine hydrochloride monohydrate, showing a benzene ring with two methyl groups and attached functional groups including amide and amine moieties, along with hydrochloride and water molecules.*
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
A data table listing drug classes and their examples. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with examples such as lidocaine under Local anesthetics, and acetaminophen under Other drugs.*
FDA Label Image

Dosage 1 (Dosage 1)

Dosage 1 (Dosage 1)
A table presenting different lidocaine HCl injection solution concentrations and their corresponding package forms and volumes, including 1% in 30 mL single-dose teartop vials, 1.5% in 20 mL single-dose ampuls, and 2% in 10 mL single-dose ampuls.*
FDA Label Image

Dosage 2 (Dosage 2)

Dosage 2 (Dosage 2)
A dosing guideline table for Lidocaine Hydrochloride Injection USP without Epinephrine, showing procedure types, concentration percentages, volume ranges (mL), and total dose ranges (mg) for various infiltration, peripheral nerve blocks, sympathetic nerve blocks, and central neural blocks procedures.*
FDA Label Image
FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
Label for Lidocaine HCl Injection USP 0.5% (5 mg/mL) in a 50 mL multiple-dose vial, containing 250 mg per 50 mL. Distributed by Hospira, Inc., Lake Forest, IL. The label notes use for infiltration and nerve block, states it is not for epidural or caudal use, and includes preservative information along with lot and expiration date placeholders.*
FDA Label Image

Rfid Label (51662 1416 1 Rfid Label)

Rfid Label (51662 1416 1 Rfid Label)
LIDOCAINE HCI injection solution label features a GS1 DataMatrix barcode with associated application identifiers including lot number and expiration date. The label instructs to see the manufacturer's insert and states the product is distributed by HF Acquisitions Co LLC in Mukilteo, WA 98275.*
FDA Label Image

Serialized Labeling (Serialized Labeling)

Serialized Labeling (Serialized Labeling)
LIDOCAINE HCI 0.5% Injection, USP multiple-dose vial containing 50 mL (250 mg/50 mL or 5 mg/mL) solution for injection. The label shows the distributor as HF Acquisition Co LLC and the manufacturer as Hospira, Inc., Lake Forest, IL. The vial cap is purple, and the label includes lot number and expiration date information.*
FDA Label Image

Pouch Label (51662 1416 2 Pouch)

Pouch Label (51662 1416 2 Pouch)
Label of LIDOCAINE HCl Injection, USP 0.5% (5 mg/mL) in a 50 mL vial. It lists the NDC 51662-1416-2 with lot number and expiration date. The label indicates the product is for infiltration and nerve block, is sterile and nonpyrogenic, and contains preservatives including methylparaben. Manufactured by HF Acquisition Co., LLC in Mukilteo, WA.*
FDA Label Image

Vial Label (51662 1416 2 Vial)

Vial Label (51662 1416 2 Vial)
Label for Lidocaine HCl Injection, USP 5 mg/mL (0.5%) multiple-dose vial, 50 mL total volume, distributed by Hospira, Inc. The label indicates use for infiltration and nerve block, warns against epidural and caudal use, and notes the presence of a preservative.*
FDA Label Image

Case Label (51662 1416 3 Case Label)

Case Label (51662 1416 3 Case Label)
Label for Lidocaine HCl Injection, USP 0.5% (5 mg/mL) in a 50 mL vial, sold as a case of 25 vials. The label includes NDC 51662-1416-3, lot number, expiration date, storage instructions, and notes on contents and usage. The product is manufactured by HF Acquisition Co., LLC, Mukilteo, WA.*
FDA Label Image

Label (51662 1416 3 Case Rfid)

Label (51662 1416 3 Case Rfid)
A close-up of a white pharmaceutical label displaying a GS1 DataMatrix barcode and several GS1 Application Identifiers including a Global Trade Item Number (GTIN), expiration date, serial number, and lot number. The text includes distribution information by HF Acquisition Co., LLC in Mukilteo, WA. The label is part of the packaging for LIDOCAINE HCI injection solution, 5 mg/mL, by HF Acquisition Co LLC DBA HealthFirst.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.